Revised SPC: Entyvio (vedolizumab) – all strengths
SPC updated with addition of Interstitial lung disease as an adverse drug reaction (frequency unknown).
Source:
electronic Medicines compendium
SPC updated with addition of Interstitial lung disease as an adverse drug reaction (frequency unknown).
electronic Medicines compendium